Evaluating Technology with Birth Defect Risks: A Decision Framework

Deciding whether to use a technology that may increase birth defect risk requires a structured, values-informed analysis. This framework applies to medical interventions, occupational exposures, environmental contaminants, and consumer products.

Decision Framework

  1. Characterize the Risk:
    • Specific defects? Magnitude (absolute vs. relative risk)? Timing (critical windows)?
    • Quality of evidence (animal vs. human, cohort vs. case-control, confounders).
  2. Identify Alternatives:
    • Safer technologies? Non-technological approaches? Delaying exposure?
    • Comparative effectiveness & safety.
  3. Assess Risk Mitigation:
    • Dose reduction, exposure controls, monitoring, supplementation (e.g., folate for antifolate drugs).
    • Feasibility, cost, compliance.
  4. Contextualize Benefits:
    • Maternal/fetal benefit of the technology (e.g., seizure control, cancer treatment, diabetes management).
    • Consequences of not using it.
  5. Personal Values & Circumstances:
    • Reproductive plans, risk tolerance, religious/ethical beliefs, social support.
  6. Societal & Ethical Dimensions:
    • Equity of access, precedent-setting, intergenerational justice.
  7. Expert Consultation:
    • Teratology information services (MotherToBaby), genetic counselors, MFM specialists, occupational medicine.

Guiding Principles

  • Precautionary principle: Favor lower risk when evidence uncertain.
  • Proportionality: Restriction level matches evidence strength.
  • Autonomy: Informed, voluntary decision by the affected individual.
  • Revisability: Re-evaluate as evidence evolves.

No universal answer exists. The process—transparent, evidence-based, patient-centered—is the standard of care.

Pregnancy & Health - Related Articles